Skip to content
Ostentus
  • Home
  • About us
    • Overview
    • Management
    • Directors
    • Advisors
  • R&D
    • Overview
    • Research Program
    • Timeline
    • OST-01
    • Presentations
  • News & Media
    • 2025 Publication
    • 2024 Publication
    • 2023
    • 2022
  • Investors
    • Investors Contact
  • Contact us
Ostentus
Close menu
  • Home
  • About us
    • Overview
    • Management
    • Directors
    • Advisors
  • R&D
    • Overview
    • Research Program
    • Timeline
    • OST-01
    • Presentations
  • News & Media
    • 2025 Publication
    • 2024 Publication
    • 2023
    • 2022
  • Investors
    • Investors Contact
  • Contact us
Ostentus
Toggle menu

News & Media

2023 NEWS

Ostentus Therapeutics, Inc., and City of Hope to Continue Studies of Novel OST Natural Products for Treatment of Leukemia and Other Cancers

BusinessWire 05/31/23

Email us

info@ostentustherapeutics.com

Copyright © Policy Ostentus Therapeutics Inc. 2025
Website Privacy Policy | Website Terms of Use | Privacy Policy for California Residents